1
|
Ang TL and Fock KM: Clinical epidemiology
of gastric cancer. Singapore Med J. 55:621–628. 2014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Wu CW, Lo SS, Shen KH, Hsieh MC, Chen JH,
Chiang JH, Lin HJ, Li AF and Lui WY: Incidence and factors
associated with recurrence patterns after intended curative surgery
for gastric cancer. World J Surg. 27:153–158. 2003.PubMed/NCBI
|
3
|
Kim VN: MicroRNA biogenesis: Coordinated
cropping and dicing. Nat Rev Mol Cell Biol. 6:376–385. 2005.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Bentwich I, Avniel A, Karov Y, Aharonov R,
Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, et al:
Identification of hundreds of conserved and nonconserved human
microRNAs. Nat Genet. 37:766–770. 2005. View Article : Google Scholar : PubMed/NCBI
|
5
|
Liang H and Li WH: Lowly expressed human
microRNA genes evolve rapidly. Mol Biol Evol. 26:1195–1198. 2009.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Rodriguez A, Griffiths-Jones S, Ashurst JL
and Bradley A: Identification of mammalian microRNA host genes and
transcription units. Genome Res. 14:1902–1910. 2004. View Article : Google Scholar : PubMed/NCBI
|
7
|
Lee YS and Dutta A: MicroRNAs in cancer.
Annu Rev Pathol. 4:199–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Zhu K, Liu D, Lai H, Li J and Wang C:
Developing miRNA therapeutics for cardiac repair in ischemic heart
disease. J Thorac Dis. 8:E918–E927. 2016. View Article : Google Scholar : PubMed/NCBI
|
9
|
Liang W, Gao S, Liang L, Huang X, Hu N, Lu
X and Zhao Y: miRNA-34b is directly involved in the aging of
macrophages. Aging Clin Exp Res. 29:599–607. 2017. View Article : Google Scholar : PubMed/NCBI
|
10
|
Shi C, Huang F, Gu X, Zhang M, Wen J, Wang
X, You L, Cui X, Ji C and Guo X: Adipogenic miRNA and
meta-signature miRNAs involved in human adipocyte differentiation
and obesity. Oncotarget. 7:40830–40845. 2016.PubMed/NCBI
|
11
|
Petriv OI, Hansen CL, Humphries RK and
Kuchenbauer F: Probing the complexity of miRNA expression across
hematopoiesis. Cell Cycle. 10:2–3. 2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Hunter T: Cooperation between oncogenes.
Cell. 64:249–270. 1991. View Article : Google Scholar : PubMed/NCBI
|
13
|
He L, Thomson JM, Hemann MT,
Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe
SW, Hannon GJ and Hammond SM: A microRNA polycistron as a potential
human oncogene. Nature. 435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
14
|
Yu Q, Yang X, Duan W, Li C, Luo Y and Lu
S: miRNA-346 promotes proliferation, migration and invasion in
liver cancer. Oncol Lett. 14:3255–3260. 2017. View Article : Google Scholar : PubMed/NCBI
|
15
|
Zhang Y, Wu YY, Jiang JN, Liu XS, Ji FJ
and Fang XD: MiRNA-3978 regulates peritoneal gastric cancer
metastasis by targeting legumain. Oncotarget. 7:83223–83230.
2016.PubMed/NCBI
|
16
|
Kumar MS, Lu J, Mercer KL, Golub TR and
Jacks T: Impaired microRNA processing enhances cellular
transformation and tumorigenesis. Nat Genet. 39:673–677. 2007.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Garzon R, Marcucci G and Croce CM:
Targeting microRNAs in cancer: Rationale, strategies and
challenges. Nat Rev Drug Discov. 9:775–789. 2010. View Article : Google Scholar : PubMed/NCBI
|
18
|
Song JH and Meltzer SJ: MicroRNAs in
pathogenesis, diagnosis, and treatment of gastroesophageal cancers.
Gastroenterology. 143:35–47, e2. 2012. View Article : Google Scholar : PubMed/NCBI
|
19
|
Su Z, Zhao J, Rong Z, Geng W and Wang Z:
MiR-451, a potential prognostic biomarker and tumor suppressor for
gastric cancer. Int J Clin Exp Pathol. 8:9154–9160. 2015.PubMed/NCBI
|
20
|
Du Y, Xu Y, Ding L, Yao H, Yu H, Zhou T
and Si J: Down-regulation of miR-141 in gastric cancer and its
involvement in cell growth. J Gastroenterol. 44:556–561. 2009.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Zhao X, Yang L and Hu J: Down-regulation
of miR-27a might inhibit proliferation and drug resistance of
gastric cancer cells. J Exp Clin Cancer Res. 30:552011. View Article : Google Scholar : PubMed/NCBI
|
22
|
Cao W, Fan R, Wang L, Cheng S, Li H, Jiang
J, Geng M, Jin Y and Wu Y: Expression and regulatory function of
miRNA-34a in targeting survivin in gastric cancer cells. Tumour
Biol. 34:963–971. 2013. View Article : Google Scholar : PubMed/NCBI
|
23
|
Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun
S, Hong L, Liu J and Fan D: miR-15b and miR-16 modulate multidrug
resistance by targeting BCL2 in human gastric cancer cells. Int J
Cancer. 123:372–379. 2008. View Article : Google Scholar : PubMed/NCBI
|
24
|
Yang L, Liang H, Wang Y, Gao S, Yin K, Liu
Z, Zheng X, Lv Y, Wang L, Zhang CY, et al: MiRNA-203 suppresses
tumor cell proliferation, migration and invasion by targeting Slug
in gastric cancer. Protein Cell. 7:383–387. 2016. View Article : Google Scholar : PubMed/NCBI
|
25
|
Zhang R, Li F, Wang W, Wang X, Li S and
Liu J: The effect of antisense inhibitor of miRNA 106b~25 on the
proliferation, invasion, migration, and apoptosis of gastric cancer
cell. Tumour Biol. 37:10507–10515. 2016. View Article : Google Scholar : PubMed/NCBI
|
26
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
27
|
Kabir NN, Sun J, Ronnstrand L and Kazi JU:
SOCS6 is a selective suppressor of receptor tyrosine kinase
signaling. Tumour Biol. 35:10581–10589. 2014. View Article : Google Scholar : PubMed/NCBI
|
28
|
Szász AM, Lánczky A, Nagy A, Förster S,
Hark K, Green JE, Boussioutas A, Busuttil R, Szabó A and Győrffy B:
Cross-validation of survival associated biomarkers in gastric
cancer using transcriptomic data of 1,065 patients. Oncotarget.
7:49322–49333. 2016. View Article : Google Scholar : PubMed/NCBI
|
29
|
Abu-Elneel K, Liu T, Gazzaniga FS,
Nishimura Y, Wall DP, Geschwind DH, Lao K and Kosik KS:
Heterogeneous dysregulation of microRNAs across the autism
spectrum. Neurogenetic. 9:153–161. 2008. View Article : Google Scholar
|
30
|
Sayed D, Hong C, Chen IY, Lypowy J and
Abdellatif M: MicroRNAs play an essential role in the development
of cardiac hypertrophy. Circ Res. 100:416–424. 2007. View Article : Google Scholar : PubMed/NCBI
|
31
|
van Rooij E, Sutherland LB, Liu N,
Williams AH, McAnally J, Gerard RD, Richardson JA and Olson EN: A
signature pattern of stress-responsive microRNAs that can evoke
cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA.
103:18255–18260. 2006. View Article : Google Scholar : PubMed/NCBI
|
32
|
Murakami Y, Yasuda T, Saigo K, Urashima T,
Toyoda H, Okanoue T and Shimotohno K: Comprehensive analysis of
microRNA expression patterns in hepatocellular carcinoma and
non-tumorous tissues. Oncogene. 25:2537–2545. 2006. View Article : Google Scholar : PubMed/NCBI
|
33
|
Perkins DO, Jeffries CD, Jarskog LF,
Thomson JM, Woods K, Newman MA, Parker JS, Jin J and Hammond SM:
microRNA expression in the prefrontal cortex of individuals with
schizophrenia and schizoaffective disorder. Genome Biol. 8:R272007.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Chhabra R, Dubey R and Saini N:
Cooperative and individualistic functions of the microRNAs in the
miR-23a~27a~24-2 cluster and its implication in human diseases. Mol
Cancer. 9:2322010. View Article : Google Scholar : PubMed/NCBI
|
35
|
Xi Y, Shalgi R, Fodstad O, Pilpel Y and Ju
J: Differentially regulated micro-RNAs and actively translated
messenger RNA transcripts by tumor suppressor p53 in colon cancer.
Clin Cancer Res. 12:2014–2024. 2006. View Article : Google Scholar : PubMed/NCBI
|
36
|
Ma S, Liu M, Xu Z, Li Y, Guo H, Ge Y, Liu
Y, Zheng D and Shi J: A double feedback loop mediated by
microRNA-23a/27a/24-2 regulates M1 versus M2 macrophage
polarization and thus regulates cancer progression. Oncotarget.
7:13502–13519. 2016.PubMed/NCBI
|
37
|
Liu X, Ru J, Zhang J, Zhu LH, Liu M, Li X
and Tang H: miR-23a targets interferon regulatory factor 1 and
modulates cellular proliferation and paclitaxel-induced apoptosis
in gastric adenocarcinoma cells. PLoS One. 8:e647072013. View Article : Google Scholar : PubMed/NCBI
|
38
|
Zhu LH, Liu T, Tang H, Tian RQ, Su C, Liu
M and Li X: MicroRNA-23a promotes the growth of gastric
adenocarcinoma cell line MGC803 and downregulates interleukin-6
receptor. FEBS J. 277:3726–3734. 2010. View Article : Google Scholar : PubMed/NCBI
|
39
|
Zhou L, Liang X, Zhang L, Yang L, Nagao N,
Wu H, Liu C, Lin S, Cai G and Liu J: MiR-27a-3p functions as an
oncogene in gastric cancer by targeting BTG2. Oncotarget.
7:51943–51954. 2016.PubMed/NCBI
|
40
|
Liu T, Tang H, Lang Y, Liu M and Li X:
MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by
targeting prohibitin. Cancer Lett. 273:233–242. 2009. View Article : Google Scholar : PubMed/NCBI
|
41
|
Zhang H, Duan J, Qu Y, Deng T, Liu R,
Zhang L, Bai M, Li J, Ning T, Ge S, et al: Onco-miR-24 regulates
cell growth and apoptosis by targeting BCL2L11 in gastric cancer.
Protein Cell. 7:141–151. 2016. View Article : Google Scholar : PubMed/NCBI
|
42
|
Yuan X, Liu C, Yang P, He S, Liao Q, Kang
S and Zhao Y: Clustered microRNAs' coordination in regulating
protein-protein interaction network. BMC Syst Biol. 3:652009.
View Article : Google Scholar : PubMed/NCBI
|
43
|
Masuhara M, Sakamoto H, Matsumoto A,
Suzuki R, Yasukawa H, Mitsui K, Wakioka T, Tanimura S, Sasaki A,
Misawa H, et al: Cloning and characterization of novel CIS family
genes. Biochem Biophys Res Commun. 239:439–446. 1997. View Article : Google Scholar : PubMed/NCBI
|
44
|
Lai RH, Hsiao YW, Wang MJ, Lin HY, Wu CW,
Chi CW, Li AF, Jou YS and Chen JY: SOCS6, down-regulated in gastric
cancer, inhibits cell proliferation and colony formation. Cancer
Lett. 288:75–85. 2010. View Article : Google Scholar : PubMed/NCBI
|